Abstract | OBJECTIVES: DESIGN: SETTING: Laboratory investigation. SUBJECTS: Cynomolgus macaque (n = 12) and samples of plasma from patients (n = 16). INTERVENTIONS: The neutralizing antihuman C5a antibody (IFX-1) was administered to investigate the new treatment strategy for paraquat-induced systemic inflammatory responses in cynomolgus macaque model. In addition, C5a activation in plasma of paraquat patients was blocked by IFX-1 to investigate the blockade role of anti-C5a antibody in activation of inflammatory cells. MEASUREMENTS AND MAIN RESULTS: Dysregulated complement activation and the subsequent cytokine storm were found in patients with acute lung injury and in a primate model of paraquat poisoning. Targeted inhibition of C5a by IFX-1 led to marked alleviation of systemic inflammatory responses and multiple organ damage in the primate model. In addition, blockade of C5a activity in plasma from patients completely inhibited activation of CD11b on blood granulocytes from normal donors, suggesting that IFX-1 may alleviate the excessive activation of inflammatory responses and have clinical utility for patients with acute lung injury. CONCLUSIONS:
|
Authors | Shihui Sun, Yuting Jiang, Renxi Wang, Chenfeng Liu, Xiaoling Liu, Nianping Song, Yan Guo, Renfeng Guo, Lanying Du, Shibo Jiang, Yan Li, Zewu Qiu, Guangyu Zhao, Yusen Zhou |
Journal | Critical care medicine
(Crit Care Med)
Vol. 46
Issue 5
Pg. e419-e425
(05 2018)
ISSN: 1530-0293 [Electronic] United States |
PMID | 29293144
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Neutralizing
- Herbicides
- Complement C5a
- Paraquat
|
Topics |
- Acute Lung Injury
(chemically induced, immunology, therapy)
- Animals
- Antibodies, Neutralizing
(therapeutic use)
- Complement Activation
(immunology)
- Complement C5a
(antagonists & inhibitors, immunology)
- Herbicides
(toxicity)
- Macaca fascicularis
- Paraquat
(toxicity)
- Pulmonary Edema
(therapy)
|